<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Streptococcal peritonitis in patients on peritoneal dialysis: Antibiotic selection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Streptococcal peritonitis in patients on peritoneal dialysis: Antibiotic selection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Streptococcal peritonitis in patients on peritoneal dialysis: Antibiotic selection</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAawAAAGDBAMAAACFHDl8AAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAKlBMVEX///8AAACIiIi7u7tERETl5eUiIiJqamqZmZkREREzMzPMzMxVVVWqqqp7Jj97AAAc0ElEQVR42uyc328T2RXHr8fjX7Ej+WTwbyKNl6nZoD54oM2W9sWxCqxoH8bZENZsHjyhJqz2ZQyBVOxWshPIsuUlCYrkiiLF2fX+EC8J1bal6oODUNFKfUikfSj71/ScO7bzm1+NjdedqwjLM3Ov72fOOXO/M3MOjFnNalazmtWsZjWrdVKzQUe1A8PqrJNsYVlYFlb3Y9mS+33pZCwR+uhfuTFhiTEh9bJYr0bZVixDXSGsxnfpVazVyVieTyFcglJyLfpeNPI3CKC1CrDCBHhgq4RxjEpYVPKVkBtCjgogRwEefhjV1vAvUoCSWkrOCnq00t9pWCWN3UAnPF7tOSKJBndCmuPqyqRNTuAY8oBY9dUeJVlpLGX7BeT6mZAffava81YeraXKGcTKZ+TJToutsDAfRKx3AK76XSZWIqSxWTZoS86So6kjsrMo3q7AaJG8LhEaTolTAFMG7WOElbIllU6zFsusXxcNtBazI1Y/v2R4imitJ3Ws66Lsq60OGhtjtVUKJs90KjtdRZsx27rKbMXTnYklwiU3xRbMIFYBY+vUfFTjscWx4KIoOyohAfQP9EqSOeajw3CYrUFxKOKCEh73ZQdivU7bvgJ0jcroUqzntbe7EuuHp9WOwtrlWHb/7oPi/hcN44D9x2g9lrRd+KhMRSw+CYWZ1zRpDyyHtAu9cQHE/vzE/PCk+gaxdjR101qNee6F5d29Sdlp7bfbbq14cCUIhag9GlyRVNRyaxHGSmAk9KoeVIUPo+/5L8A1CCl2vY+5IByNrAxCMTxRgOJZMMYd95kTrs6XhXSAiZUQrWTpcABCJyNFHEHNwBUuJc2mB1eiUByENmB577lqfa585kTMV5NUFIF52uoOJM6VyQnzo0f8//beRSf0yNxaKBDLvXOHGXMt/dYbm3Xn8OR75M+GL+IaXlv9p5F9eJGccMG9SCOQE26Ru06jT8gttMNaboCchILghF/ISSh63jFw4x8hoLDLPLbEq/7L7F3EymimE7quAQQkNgC5NAtnf1lErIxmG07x27NZgOkUYjkCjI9AWCQlzSAsgCG58wF7W6yFk+VYPQZhcWtN9PJJaTit7AxaSzpWt1Y/CcQy9nD0u3Lp3oDwDePWGjCxNsYMDCe7/xhbEBY51pIpJRnzpdAF8CfcuQWhLbGFp5CwIKoRVnIoQvFGWBcwtuCwHWPLeISxNY83zIUwYg2ifdlQMDcEsqOPsOwYWyl+S433XsOI9Yhii7C881e4lEQljLqxEiSsUrSNV0K7/5XHSWOvxa36WH7Owd+/meX49bB6jJfFsh6oWVgHOZCyTYjY4SUeNNEVJX5IbnZqA1YheC3T0AGsR37O005lE6seR+p+PZTtgYZYDolvUtqEJVTtS8+a3zYBn2+tTSzP3sbaheX1i+20lm8J7xtC1/WHkLoOciU6AqkxyBWiWhze18NP2d1BkJntVxXUS4oLYriI4Ue4BDN62K4DGVuJj8ApVf8z4GWRa75i+rSCB8yXTZXohhBiOWHyJ7hqKbxT67EchcPaMvtC+94hfeFd/IT92iGd1YS8862PmFpk497AMnU5vkRmsq0zLhDpEaKn+Mwjq+SfiWTi3LKa/J0b14g+YQ4l41kNnRCV4khKHTOyK6w0TDc4Isfindpxyegx7jliDh1iMW/gsTfgiAWYZ71nYJ09ZY6YsDQbwi4/X/sasQT9GglE/ggxA5DROJbCpthRlaVp6ZPsAZSMaYotVIojcmYU4DZJjyYW79R6rJ9qo3cC3oA3xnrnLhTve2PiA4mhysvK7AnrDfzDoHjDS0aCB1UZBaLCHyGi0vPIcRMrcW68geXKlWmhVvAAeQCxUCU6jQ0TSw6LZK14O7A+hQXH/JUlVoCj0McqS4VDWiHyPnzuhv6/grGm/4dentiOQxixslCl2OKPEGf0oBsqJpaIsWViQTA5SNpecfPYkjPn0FSg17Hi0ZzCO7Vz3eqR//expc5bjj3rXYllaUILy8KysP6PsLozQ60rjW5hWVgWloXV/uZYsbFvuxDrUOlmoAvNtQZQ60KsVWi+PO2mJsKhbrxmuOmhTRe2+bmuxIrLXYnFX/13X7Mzq7VDzFn1Wz+mZxkWloVlYbUfS932Kie9bZ+Zy7lnYvi2PP5Rs0qqvrxR3oa6fzb5QWKJENV2T1yURXmZvSxWcx+lRZpY9UqZSXMo8wt/GbiJpbQUy8juoehoJnfZa1irjmWr36o83orF8zbaZS0jSym3cUileTmWEz7CzxLcPAoTKedMNLKCuwpQRKzEfFVVp+GBWAkJl6LnUyJl396acFXTIzDHXDUmfB6AUEKv1k1xMnIbAgyHqoTYGvpEIUhvloXUycitGGP3FZ6rsSWh6ICdsFjuvdcvIBaVYzE2gZ90iiUXYknix7iLuZYI69y4Kq+uTIq11Yf57K1AZph2ZP+lpVX04965Sd8RP73rL9exFtyLaW6tlDpcRQ+08awNIYXbl0fvzCm4fWzJ1iIsQ4gBhHOERQU+5yGEn00sv+v3uIun4+JUz6hUtiXKtumUs5ie4jvc/SztisjM0X/ms7/w2LpsYlGWroklZ84DUDUXZW0Ip3D7J38Yr1HChlnx1RqsxTLzxnx1rJL2FWEZiCXkTiLWxzHfKUrHxak6yiqVbYnyxjBiDd4TaAdZi3kDjH1350+Um9vEoixdwsKhMsPkmGStcbKWsPgo951MWPWKr1Y4YbA4CLlCsI51ASbw0w03Zcmhf8MrtoKpoSBhxaGmUtmWCH0CYvWkBNyRH/dV0yolOQ1oX1FuLseyYVBhbFFE0lAZbQ2KiNWIraJH3qCsocwHup5s6brlM/Y9qrFL2XKZxJZNHshjK62VWEPRfe9wm7t2YN04iBtQXtVsiacfF5aLHjW2Aus5Bd1x/86DXqDuRvv204hca+4VYfCz1mPZklu/NauyNgv7d6i7nW1yUyPyCi6VCy3zcPVNYm09qFmVtYn1AnX3eBOraa3GwXtjCQeN5YJwQ5vZ9b4LYKiVewXInIhGvpXcOVSLZlWWqORQ3ZUqYQcKPFR3k7zIh7G1CC5kGVy/lcvzfT6oNpQgZeVeio7CRT8pSexE9VuU66sH8Qfsetg2O8V/2Sln1ylN8cCtdYO0WQoN4ZEp/1ZNnkEnPCGJ1xCr3DtnVmWNVLm15ISPMm5tyTqWkKfafsKqigY7pi03lCDKleF8dgadkJSFr/boODrhgmmt5BlP8ZmtRr9cW/17bpa1AMvMtuXaLKOhQHhXZVOE5XchVh7wxPOqrBHZdMJZJ3C9UMdyGSQSCUu2V35TgFBDCbopK9c5w2PrjOositMpEoOmE05Rdm/S/K8Cbt39ms/kgLEo27auzbi1JMJaJywjLFK2rVmVxbEMxOKSA9Wdvdy01hNb8TQt0U+PaU0lyLNynTMBKkwro7VWjy/VraXhD3jozPBf3tCOzbXCWiJc4tqsgrE1z2OLTbkwthArHsXYyplVWTRtKuyfxSjUcE7/Ze98fts4rjj+tEtqKZMGdrRaiiItYNUoSqxcuBBgQEYP5KKxUreHpWsJFZMDKVuOCvWw8s/A8YGMa6FBL5INoUrUAFIQ1Ye2AFU4bZWTjARVkfogoyeh/0znzZD6ZVuW06W4pN87KCFlDfnh27f73eHM940lBRZksbYU9keu09l0DL8RkkpQwVW57fdWLumoJHltReevZoZ5beXj/AXUYhwF4hW0TslZUJfaamDghzXstpzKQKyHpAkJi7CaGQunH7qevzb/1Vfsv9Kf1ANLq92ncqxt9zCsT1kpxDx1fvrQobPQ11NqKNYJJLpZGbZqWP1wGNZHytzA6Bcd1u3D7wtx93jjsb4AZdk5J6ZvwyxhlOGWwlLSPSHHVmdYoS9ZMYREh5Nzm+Cs4eYrsbEuz/h7P8PupVSzL15JXDZUrv1u98GvL2yIPXd8kImwadv9bO7Ysfi9YqRw3pXTtzxbHIurROmeAOFeGPtdSssYQqLD2JaDE6G2C2Jj3feYEi71R2IfL2kbp7j28rhWLMPguTTuuSvwQRDLst1GZQtq07eINQtV94RHLBFdjBTUgoESHaKLsJMt3Ko1xbHCXOoP536JHg4wzO8EuM5PmZg19FkAE7EAp36P/ZSBteWEq9O3YNijDzFbwj3hdjixnsZ5X0NI9IEK1GpLYHHVz7PFRftl4eEAoT+L261ob0RgFfggIwrHElO/jTgTOiCnbzlWqOehrC2ONRxPZJkua4tL9CK/q62eCQXW3+KitgoRQ3g4wElxmihXz4SRAh/ETnIsMfXbRJfjA1n4geZVQcOy2f6aGd8i8URYhPVaKXjfQ4z5UjOYeiv4Wog3gvPo4lGZGQpbFdcr/JHthr7dL8Wc2jx2dne6fT9W29AxYz2j4A9gVR/NojvrQ6Eu+A9lcvy/qT2+OlUsjT3vwtWQbB1U8MBV+3UY+Yb9k00yOY+Oay3KzBqEfqEF+Y+YF/oROlJFdM3jMt2ZYY9QoXPlDjjdfo6d63H74l+jV1SMdeJqjyEdfdYaqOC5as+NmoPi8839R8yj4/RuJNUPA1K5g33RCl3NKAWBxWU6PwhRoaNyFwfhTyJG+ztL2rcoQAZcB1d7DOnos9ZQBT8Vesv7IHlXj2aZnEefEreRL8gWF34cCxU6V+66wOJaMfQ2F/Qz9wFugYOrPYZ09FlrqIKfUn9VAeWSqS3nxDw6Yv0rslCtrft7aks18xJrS2pDzNayxHqHC3r8Jn9gdAJXewzp6LPWUAU/BV9xOX5v5dJ8EefRBRZX5PJMGF3YeybMfi6wNFYWCp1j4XS7I0wx2DW8Qcv3TOBqjyE93Nnoy3H4wSHzFNYPfLl9PmsNwdKW63BVPuGReCIswiIswjomLPLLaJqkExZhERZhHX+QX0ZTBfllNFOQX0ZTBfllNFOQXwYF3R2/JnMZhEVYhHUcWEdteLu7APclizhC1qHr1Q70AvEZS2UFCbUH69B3buw86xzyYfSLty2xDi5ewMeqzn+Pr5OrLjT0O1s2vDIWHAULXoi1P1vRVJ2wsOvcDMutJNQiv8n4hm2yhJHowwZ0v2WJ4Z7SGfYmbqA8FWNzxXgFs3WRzeFOrXY2PcMusGlcHv+2rt3I9sgdludFFzx01sjI/ZWFbJdb63l3RbTJ+1Zky15ZwjXB9cHqldmyBjpK2wCD2K6jU/S6U+YcXF99H2Ib6z/OwICLG+kQy3aruyA/bEuvV+4AjOBahmsm7tnbDC/9PJrCg3Bj7a8Zub9SmcxbtZ53uGnyu+pBaKdH4HSpTljYdQ4PwtkcYy58kCwZqi563ammg+urTWgvhWZLcEu2pQO0yHgTd0EKe40yiwOc7fqHrnkz97mcL7KEAwlRW22fvCv3V2qe4u30vGu/q0/VsPiYU1Cv2sLdilscS3SfA6XQq+pinbRWGMH11ZitNZEt0ZYOiypq4i5IXHCxtS6mMmLXzLwHa+M8W/z3J81BxHp6ISP2V5rK5Ji10/OufU+2OFa9zoST2HVOY7n0rFqMozFGaSah4zppFk+XsbaGq7UVYgvYlg4PQuZhbeXZhxqvrW6AbLyS/fwa6xY7LM0ss9Z5baGzBu6vDK/I2qr2vONYO7VVv2wd5Qr1iuG86DoWCJXRolikCQmLsAir9bFoXUbTJJ2wCIuwCIuwCKvpsVpUUuitmWHCIizCIizCalEsCgoKiv8v1JZYYfzMV1PaittEb398K7ZxJKzxs5bPL62cgol6YSmT2+6RsAYic36/9GelumHByITCprGzCmS7fmEkQJPtWBxtNclKeeZ9CbCJq0Emwot+Y00s8Nf+U32wcpn1yh1p3pF/oxNAtmPxnOtov/ck+uBOyFuy0yOquWvw7tuB8vuJtcr1+mCFrDKLo3mH5inXdImla95PF9DQbQre2/7kL3PC6hmXoPiLVejrnIUz9cLCdSJRk394Y2/o+GLYjsUbuelyrCdRo2Ph9Mae1SC+YrV3rlW+qxeWwrqFvR6vLY5VbcfiaNMci9dWLJMr1Qsr0lm32qKgoKCgoKAIZujH9Do0/UlYhNUCWO+DHnVbDyv3XiLbglgxxk614EEYZSzViqeMLMu0IlaZlVoRq6OnJa9bSmdLYoXNlsSCdGtiQZNh+btDQQ8MVrAUMWERFmE1K9Yhu3D7mwcrwuLWPijjAGT1MRpGNBNWQbl/KBY0KRYMqvOLajGh8XtGjZlJVkJPCzUZrxTjf2cmNhwcKK7OMBdkH8I7MJLH72KL8UqgsewO69Px0nbblshOpyJ7hqdiG8IMAxsODowuYrZkH0L7fXMzjG0u2r1gZyvntuUYu1C8IQ7CWs9wZVKYYWDDwX6Ykgch9iEMveUVWUJYZQS6thY7rNPjeBu8CNCLqzBkz/ATH5knvF7MFvJgLmUfwshn6U38Q/OEF+gzYUnUVnwcm3bOmBxL9AxnydGVuDeDtZXgPBoTdMPxBFyGPE9nmP+2+S7H6qu8VcIi8dRIrDNuM2DZR+nKuaeDW/QPqwHD2g8wnn4u1sHFn/jY4VioozQ2Devp/iBjKexoWPuz9QS+FFojSFg5lk3bF4WPWVXKcsFnC5cz51yeGdfRMYwl+pIVIRCFh1rJUVhKZCuEf3UrkNnSvFvSx6xSdarjgk9Bl7Pz7vdg5EZNnq1oSsugQPy38FArOGtpeRCGMrb7aDWQtaUumNLHrCSxuOCzFXQ5c2AKDK79OBb2oUaBOIUeapGCM1utrZCVc/n/w9mgnQmVZTi/IX3MqgchF3yYLayoJ1EDG9rBCPahRoH48ZLowrybLWuPiXOQsKLz3tO09DFz+SmDlwoXfKK2Cg5gk+mv+L8ry9piSRd7TXOsndqqZiuIl+P+Fxt+Rc09De1epqSChRX+4oVYNrP2NLRrLizShIRFWIT1emO15reRx5UGwiIswiIswiIswjoGpRE8rOC8IcIiLMIiLMIirGYKwiIswiIswvINyw/jMm05mgoalg/GZeGJ3ZWSQcHyw7hs+OboSndkvjNAWH4Yl2lGzBt/5AUpW34Yl6l6O2N3V34WJCwfjMtUPYap2gwSlg/GZaoeXmEXsf0lXbcIi7AIi7AIi7AIy+exaPqTsAjr9cAKV9rg60AM4tMo1bG6yr8xAzGIT6NU4zFjG8EYxKdRZKwxVgnGID6NIiPEugIyiE+jyIiwREAG8WmUaszPBWUQn0aR0WcFZRCfRpGxZ19ZgwfxaRQZamAG8WmUJg7fFgu2BaoJvO6XAm38DXkbYREWYfkdkfnu48ay96lVFKs1+4Zw0drnqnFIKM8szd63G7jdqmO2iozV1E3NcMywq1hP5eNtl0PVsDT87y6W/dzBpY9ZLl27l3wAMJY5iKWculHHbO2+sf7dXNnynmLn+V2smAUvz5bEWtuRhQaEV57Bar93vq5YaKHhldkN1g0n5yBqGsU4toSTxHn+fAJy7OqVpPs46UKZXWTvcqxa7zgFn+cJj7Du8ApLP/5fe+fz08YRxfHZXa/XYJD8vF3bmEZaWpcoKIfdVKFKTsaymgip0jppaO3mYENRSKNI69IGNclhTRT641SIqOiPSIBktVEvpK0acTNSpByaQ6JWlfrf9L1ZY7DBxE4wuKnntF6PZT5+837Ms/lO9Hy07wH0j/ThQgif6nMSb3PM7hnEGoZAAexx+W4e1pIsbR9vKdaoRcJpPg2tIvfPnSvRIjTOlLEe+++41ppMzxa7debRBy+sItbm2XF0f5H/n33h4rJwotj9uuqxVUnjL1/wLY5aHCtJi3cBreXT5nzZI4wlmXz9TmuthQ4W+QoIi63+dFPnvjVTxppiZ8uL0Ps5gI1YM+woYm2eHUf3bcTyrcCYI7wFMB1QbJXlF/DlssY0Lg2jyoCbZFmTAvg26dPOYJiX9Z+0GOsRY5d6tSF8dMz+dk01rS2sx36VsJbxz58ltROy1ji3lnt2HN2fHNOZ1356sXT/RBH9R7HRGvctspa4mCj7GreWGMC3Ee8x1uUk0XV/bjFWBrSBkLaOeeS+cY2pmRDH8tB+HX0oRgIcH8e9zgY4iOXZ9C1+dhxi3V4J6RjNcx/kcsYG0PFy+QhpdJiMfItCBlqZsArRAL6NHJTno1ayiXSsNsgU2+d0POaU20yNbBmlxbpVhgKVhs5m0PTorgomfywY1YkxnmglVvlvkaChH35V/fSt1lrqzsytVst5Vo2WYu1jTaiKCW0jegGiY5BlqTXW9ddRLu6JmFzOMzV3Da4IKxEpF/HExs9yUadRsHmGstsZa0KkPJL6Ex91vzG1ToswKJLCEZfzFEoY3QT9WJfzj6eIi5BEnZKSVslQbYsVRwe7MYKRB6Pno7+Pc9/yERaX8xSM9yAsGGYK4F0dsUjUKSFrlQzVvlhikSnLqVuY0P3f9Cx49CPbsJ4IRsH6UTCudVFMFuNc1Amx3Az1nFgNBNrrlVhoqlUxa6hhLIZJYj53eyWLia5X8+hc3NPFUiBlZOCSABNSLkRYXNQJsdwMtRNLQg/dIRpcW9Gqe+cMqtW3gvdqdSiuo2P0XOl4R0Dcdb8l0AE0JtuJVauW9GxrKVvB+041Vm/2kLBGqYaPDWCgHJwv9kDRNAvDkB15BUvytWFwcqE1xMLyO8f18TJQwqdCfRvhlGGezwVdnTzvE/Fy9LwaGQg9gMmVsJiI0PXaAMTl/oPe9JexME7G2KCBgRKrviFr1dRxEdLBz1iSk3gy6SazQYy1Xhsj7kN+JrTqjRcUe6ZLZ1wnjwkWnT0c9H+vlOgnzL9MSHT9B3nMRCux/CuheljoeTFchjxQnslD2CTf4gc/K58C9HPdZJY+fTvPFdemGH/Ko5vSopaymCsoh1hxz3TARxp6XoDZuETXU9mmsXhvoWrpb7uzs8ZQSnV6GRxrCLEoUMpLQ1SAC29q/OBnxV7iyshUiF9+ny583Fr4FGKx0RK3FmHhIoynbwX8pKHXY5OgIF1TFG5yESrxLY82a+48RV9Vq7Gkj27sioWRELHWwzGGgXIASj0QQayTK+RbiDWMnhIiLCy/6YJOfybf4lhPDWk+6GKhBeFVDDSkoYeb5XNx9zofbTZk9Oi1gapyh3oRhRos3DRYz+w8xZpb2Numy4v15GAbD/AD8GsuUoAUYAmIn6ql8saC220wTYcWVu9dlU5GC3rhypfW0Lvwtac4vN9Y8t3t6fhcHawG0zF6v8qo4NOZfISNzU5mcLMuTqYdt9tg6m4H6SRFLwutdcnrTNGZ9jeDbd7VxYqCF3y/QcS/hIvaVmmr6rjdBtMNA3kAAze6CawPxXeydKb9ZvOvbbG4tRDiuhxZNzAs6RUszDtlLCaTtS6MY30of6czvybCUrv34Mm3sOA7FYqMQMD1LRfLg77F3F4EYWX6xrE+ZJ9Z5pYo/8vz1ULihb9aUJ9ZGCrFug3s3aPGC2P1anthNV7Bq7s238txPU1htkZFWt3qthxGTdhgBa/u9Z3CDNsFq/LBZg8Dq6EKPgOqOwG9Gj049wPvqQ/Da/FRctyrXBw7BdO8g4JZlM5LiQRwSgbs3eqnNqngH+KHzyeYjLKj8aEvMOfLLuAiTFLfXSuLY7sdFMqi+CopgHU/NVEmDgOroQp+iqnuBOr7YnZMSAEs6jXqRMoci4tjx8sdFC8v92mKQ+ejHCxWMxX8Y7/qTjAtbjLEEu+xhU2sq6449nK5g+L9gs5LkQLKZesRfR1z4FiNVvC/R1V3Qob7FmHJQXYKfYtjzXBxbP/8tNtBofa8nY/QlAxoBxwymi91Y/V66um9mvAHHOBfEGt7T52nY3aQ6bgJrP9U8dTB6mB1sP6nWC/prz87ozM6ozM6ozM6ozP2e/wL6s9Q4r7vroQAAAAASUVORK5CYII="/></div><div class="graphic_lgnd">This algorithm addresses patients who are not septic or bacteremic; such patients should initially receive intravenous antibiotics. Refer to UpToDate content for dosing.</div><div class="graphic_footnotes"><p>IgE: Immunoglobulin E.</p>
<p>* The initial empiric antibiotic regimen covers both gram-positive and gram-negative organisms, and should be narrowed after a specific susceptible organism is identified. Refer UpToDate content on microbiology and therapy of peritonitis in peritoneal dialysis for details.</p>
<p>¶ There is no consensus on the optimal timing and duration of antifungal prophylaxis. We administer antifungal prophylaxis if antibiotics are administered for longer than 3 days; other experts do so for any course longer than 1 day. The duration of antifungal prophylaxis varies: prophylaxis is continued for the full antibiotic course, but we generally extend the duration by an additional week. Refer to UpToDate content on fungal peritonitis in peritoneal dialysis for details.</p>
<p>Δ Streptococcal isolates that are not tested can generally be assumed to be susceptible to penicillin and cephalosporins.</p>
<p>◊ Type 1 allergic reactions are acute IgE-mediated allergies that typically manifest as various combinations of hives (urticaria), pruritus, angioedema, bronchospasm (eg, wheezing), or hypotension. The majority of patients with reported beta-lactam allergies do not have type 1 allergies and can take a cephalosporin. Refer to UpToDate content on penicillin allergies for details.</p>
§ For patients whose catheter is removed due to infection, we administer systemic (oral or intravenous) therapy for 14 days from the date of removal.</div><div id="graphicVersion">Graphic 143369 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
